Literature DB >> 8813729

Regulation of the Mel 1a melatonin receptor mRNA and protein levels in the ovine pars tuberalis: evidence for a cyclic adenosine 3',5'-monophosphate-independent Mel 1a receptor coupling and an autoregulatory mechanism of expression.

P Barrett1, A MacLean, G Davidson, P J Morgan.   

Abstract

The Mel 1a receptor gene has recently been cloned and sequenced, and its product has been found to represent a new class of the G protein-coupled receptor superfamily. A unique aspect of its endogenous hormonal ligand, melatonin, is the prolonged duration (16 h) required to initiate appropriate photoperiodic responses in the animal. This study provides the first data on the transcriptional and translational regulation of this receptor in primary cultures of its native tissue, the pars tuberalis of the ovine pituitary. Using RNAse protection assays we show Mel 1a mRNA expression is rapidly induced through changes in intracellular cAMP levels. Forskolin enhances Mel 1a mRNA expression, whereas melatonin reverses this effect. RNA stability is also a factor, as Mel 1a mRNA expression decreases rapidly in the presence of actinomycin D. Although the expression of receptor protein is sensitive to forskolin stimulation, the lag between induction of mRNA and protein suggests that other factors (e.g. RNA splicing) contribute to functional receptor expression. Furthermore we observed that both mRNA and receptor protein levels increase spontaneously during primary culture, and these rises could be blocked by melatonin. A spontaneous rise in Mel 1a mRNA can also occur in serum-depleted cultures. In the absence of corresponding changes in cAMP, these results suggest not only that the Mel 1a receptor can autoregulate its own expression by an undefined pathway, but also they provide the first evidence that melatonin can act via a cAMP-independent signal transduction pathway to repress transcription in this tissue.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8813729     DOI: 10.1210/mend.10.7.8813729

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  6 in total

1.  Daily variations in plasma melatonin and melatonin receptor (MT1), PER1 and CRY1 expression in suprachiasmatic nuclei of tropical squirrel, Funambulus pennanti.

Authors:  Sameer Gupta; Chandana Haldar; Sarika Singh
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2013-07-13       Impact factor: 1.836

2.  A generic approach for the purification of signaling complexes that specifically interact with the carboxyl-terminal domain of G protein-coupled receptors.

Authors:  Pascal Maurice; Avais M Daulat; Cédric Broussard; Julien Mozo; Guilhem Clary; Françoise Hotellier; Philippe Chafey; Jean-Luc Guillaume; Gilles Ferry; Jean A Boutin; Philippe Delagrange; Luc Camoin; Ralf Jockers
Journal:  Mol Cell Proteomics       Date:  2008-04-29       Impact factor: 5.911

Review 3.  Epigenetic regulation of melatonin receptors in neuropsychiatric disorders.

Authors:  Sarra G Bahna; Lennard P Niles
Journal:  Br J Pharmacol       Date:  2017-10-25       Impact factor: 8.739

4.  Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers.

Authors:  Lennard P Niles; Kristen J Armstrong; Lyda M Rincón Castro; Chung V Dao; Rohita Sharma; Catherine R McMillan; Laurie C Doering; David L Kirkham
Journal:  BMC Neurosci       Date:  2004-10-28       Impact factor: 3.288

5.  Regulation of pituitary MT1 melatonin receptor expression by gonadotrophin-releasing hormone (GnRH) and early growth response factor-1 (Egr-1): in vivo and in vitro studies.

Authors:  Sung-Eun Bae; Ian K Wright; Cathy Wyse; Nathalie Samson-Desvignes; Pascale Le Blanc; Serge Laroche; David G Hazlerigg; Jonathan D Johnston
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

Review 6.  Effects of Melatonin on Anterior Pituitary Plasticity: A Comparison Between Mammals and Teleosts.

Authors:  Elia Ciani; Trude M Haug; Gersende Maugars; Finn-Arne Weltzien; Jack Falcón; Romain Fontaine
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-11       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.